Icotinib Hydrochloride
CAS No. 1204313-51-8
Icotinib Hydrochloride ( BPI-2009H )
Catalog No. M17189 CAS No. 1204313-51-8
Icotinib Hydrochloride is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 50 | Get Quote |
|
10MG | 72 | Get Quote |
|
25MG | 129 | Get Quote |
|
50MG | 215 | Get Quote |
|
100MG | 320 | Get Quote |
|
200MG | 474 | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIcotinib Hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionIcotinib Hydrochloride is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity.
-
DescriptionIcotinib Hydrochloride is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR-mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, has been upregulated in a variety of cancer cell types.
-
SynonymsBPI-2009H
-
PathwayOthers
-
TargetOther Targets
-
RecptorEGFR; EGFR mutants
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1204313-51-8
-
Formula Weight427.88
-
Molecular FormulaC22H22ClN3O4
-
Purity98%
-
SolubilityDMSO : 25 mg/mL. 58.43 mM;
-
SMILESC#Cc1cc(ccc1)Nc1ncnc2cc3OCCOCCOCCOc3cc12.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tan F, et al. Lung Y. 2012 May;76(2):177-82.
molnova catalog
related products
-
Tectorigenin 7-?O-?X...
Tectorigenin 7-O-xylosylglucoside is a natural product.
-
Tormentic acid
Tormentic acid is a natural product. It has anticancer, anti-inflammatory, anti-atherogenic , anti-allodynic, and hepatoprotective properties.
-
HJC0197
HJC0197 selectively blocks cAMP-induced Epac activation. HJC0197 is an effective exchange protein. Which straightly activated by cAMP (Epac) antagonist (IC50=5.9 μM for Epac2).